Skip to main content
NCBI home page
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2008 Jun 28;8(5):355–362. doi: 10.1111/j.1939-1676.1994.tb03250.x

Hemostatic Disorders in Feline Immunodeficiency Virus‐Seropositive Cats

Stefan W Hart 1, Ingo Nolte 1,2
PMCID: PMC7167060  PMID: 7837113

Abstract

The hemostatic function of 40 feline immunodeficiency virus (FlV) seropositive and 8 FIV and feline leukemia virus (FeLV) seropositive cats was evaluated and compared with reference values from 30 clinically healthy cats. The FIVpositive cats were divided into 3 groups: group I included asymptomatic carriers; group II comprised sick FIV‐infected cats with illnesses not likely to influence the hemostatic system; and group III included FIV‐positive cats with diseases potentially associated with coagulopathies. Platelet counts in FIV/FeLV‐infected cats were significantly lower than in healthy cats (P < .003), whereas the differences in the 3 groups of FIV‐positive cats were variable (group I, P= .009; II, P= .05; III, P= .09). Thrombocytopenia (< 145,000 platelets/μL) was present in 4 FIV‐positive and 3 FIV/FeLV‐positive cats. Platelet aggregation induced by collagen (0.5 and 0.25 μg/mL), adenosine diphosphate (ADP) (1 and 0.6 μmol/L), and thrombin (0.4 and 0.25 IU/mL) was not significantly different from that of healthy cats. The plasma coagulation system was evaluated by measuring one‐stage prothrombin time (OSPT), activated partial thromboplastin time (APTT), thrombin time, fibrinogen concentration, coagulation factor assays, fibrinogen and fibrin degradation products (FDP), and plasma exchange test. The OSPT was similar in FlV‐seropositive cats and in the healthy control group. Cats with FIV infection, however, had markedly shorter clotting times than healthy cats when using a modified test system (P < .05). In all groups of FIV‐infected cats and in those with FIV/FeLV infection, APTT measured with 2 different commercially available tests, and a modified plasma assay was markedly prolonged compared with healthy cats (APTT1 and 2:3 modification: P < .01; APTT2: P < .05 except group III). In 22 of 40 cats with FIV and in 5 of 8 cats with FIV/FeLV infection, plasma samples were beyond the reference range. The thrombin time was also significantly prolonged in cats with FIV and FIV/FeLV infection (P < .01); values in 17 of 40 FIV‐positive cats were above reference range. The mean fibrinogen concentration of cats with FIV and FIV/FeLV infection was higher than in the healthy control group (P < .001). Factor VIII activity of 4 cats with FIV infection was 1.5 times higher than that of healthy cats. Factor XII activity of 3 cats from a group of 20 cats with prolonged APTT was between 20% and 35%. Factor IX and XI activities ranged between 70% and 120%. The markedly prolonged APTT in 2 FIV‐positive cats could be shortened considerably in a plasma exchange test using 20% feline pooled plasma. The alterations in the coagulogram of FIV‐seropositive cats were not related to a clinical stage or concurrent diseases. A definite explanation of the distinct disorder within the intrinsic plasma coagulation system in FIV‐infected cats was not found.

References

  • 1. Kraft W., Gerbig T., Geyer S. Thrombozytopenie bei Feliner Infektiöser Panleukopenie. Kleintierpraxis 1980;25:129–134. [Google Scholar]
  • 2. Weiss RC, Dodds WJ, Scott FW. Disseminated intravascular coagulation in experimentally induced infectious peritonitis. Am J Vet Res 1980;41:663–a671. [PubMed] [Google Scholar]
  • 3. Hiller D., Kraft W. Fibrin‐ und Fibrinogenspaltprodukte (FSP) bei Feliner Infektiöser Panleukopenie. Kleintierpraxis 1985;30: 279–284. [Google Scholar]
  • 4. Boudreaux MK, Weiss RC, Cox N., et al. Evaluation of antithrombin‐III activity as a coindicator of disseminated intravascular coagulation in cats with induced feline infectious peritonitis virus infection. Am J Vet Res 1989;50:1910–1913. [PubMed] [Google Scholar]
  • 5. Boyce JT, Kociba GJ, Jacobs RM, et al. Feline leukemia virus induced thrombocytopenia and macrothrombocytosis in cats. Vet Pathol 1986;23:16–20. [DOI] [PubMed] [Google Scholar]
  • 6. Juchem R., Pause B. Megakaryozytenleukose bei drei Katzen. Tierärztl Prax 1987;15:195–200. [PubMed] [Google Scholar]
  • 7. Pedersen NC, Ho EW, Brown ML, et al. Isolation of a T‐lymphotropic virus from domestic cats with an immunodeficiency‐like syndrome. Science 1987;235:790–793. [DOI] [PubMed] [Google Scholar]
  • 8. Pedersen NC, Yamamoto JK, Ishida T., et al. Feline immunodeficiency virus infection. Vet Immunol Immunopathol 1989;21:111–129. [DOI] [PubMed] [Google Scholar]
  • 9. Yamamoto JK, Sparger E., Ho EW, et al. Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats. Am J Vet Res 1988;49:1246–1258. [PubMed] [Google Scholar]
  • 10. Ackley CD, Yamamoto JK, Levy N., et al. Immunologic abnormalities in pathogen‐free cats experimentally infected with feline immunodeficiency virus. J Virol 1990;64:5652–5655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Hosie MJ, Robertson C., Jarrett O. Prevalence of feline leukaemia virus and antibodies to feline immunodeficiency virus in cats in the United Kingdom. Vet Rec 1989;125:293–297. [DOI] [PubMed] [Google Scholar]
  • 12. Bennett M., McCracken C., Lutz H., et al. Prevalence of antibody to feline immunodeficiency virus in some cat populations. Vet Rec 1989;124:397–398. [DOI] [PubMed] [Google Scholar]
  • 13. Cohen ND, Carter CN, Thomas MA, et al. Epizootologic association between feline immunodeficiency virus infection and feline leukemia virus seropositivity. J Am Vet Med Assoc 1990;197:220–225. [PubMed] [Google Scholar]
  • 14. Grindem CB, Corbett WT, Ammerman BE, et al. Seroepidemiologic survey of feline immunodeficiency virus infection in cats of Wake County, North Carolina. J Am Vet Med Assoc 1989;194:226–228. [PubMed] [Google Scholar]
  • 15. Gruffydd‐Jones TJ, Hopper CD, Harbour DA, et al. Serological evidence of feline immunodeficiency virus infection in UK cats from 1975–76. Vet Rec 1988;123:569–570. [DOI] [PubMed] [Google Scholar]
  • 16. Moraillon A. Feline immunodepressive retrovirus infections in France. Vet Rec 1990;126:68–69. [PubMed] [Google Scholar]
  • 17. Furuya T., Kawagushi Y., Miyazawa T., et al. Existence of feline immunodeficiency virus infection in Japanese cat population since 1968. Jpn J Vet Sci 1990;52:891–893. [DOI] [PubMed] [Google Scholar]
  • 18. Lutz H., Egberink H., Arnold P., et al. Felines T‐lymphotropes Lentivirus (FTLV): Experimentelle Infektion und Vorkommen in einigen Ländern Europas. Kleintierpraxis 1988;33:455–459. [Google Scholar]
  • 19. Kölbl S., Schuller W. Serologische Untersuchungen zum Vorkommen des felinen Immundefizienzvirus (FIV) bei Katzen in österreich. Wien Tierärztl Mschr 1989;76: 185–189. [Google Scholar]
  • 20. Neu H., Moennig V., Leidinger K., et al. Erste Ergebnisse über die Verbreitung FIV‐ (FTLV‐)seropositiver Katzen in Deutschland und Interpretation der Ergebnisse. Prakt Tierarzt 1989;70:38–44. [Google Scholar]
  • 21. Witt CJ, Childs JE, Bishop BD, et al. Historical assessment of the prevalence of lentivirus infection in domestic cats. Lab Anim Sci 1988;38:512. [Google Scholar]
  • 22. Witt CJ, Moench TR, Gittelsohn AM, et al. Epidemiologic observations on feline immunodeficiency virus and toxoplasma gondii coinfection in cats in Baltimore, Md. J Am Vet Med Assoc 1989;194:229–233. [PubMed] [Google Scholar]
  • 23. Ishida T., Washizu T., Toriyabe K., et al. Detection of feline T‐lymphotropic lentivirus (FTLV) infection in Japanese domestic cats. Jpn J Vet Sci 1987;50:39–44. [DOI] [PubMed] [Google Scholar]
  • 24. Ishida T., Washizu T., Toriyabe K., et al. Feline immunodeficiency virus infection in cats of Japan. J Am Vet Med Assoc 1989;194:221–225. [PubMed] [Google Scholar]
  • 25. Shelton GH, Waltier RM, Connor SC, et al. Prevalence of feline immunodeficiency virus and feline leukemia virus infections in pet cats. J Am Anim Hosp Assoc 1989;25:7–12. [Google Scholar]
  • 26. Shelton GH, Cotter SM, Gardner MB, et al. Feline immunedeficiency virus and feline leukemia virus infections and their relationship to lymphoid malignancies in cats: A retrospective study (1968–1988). J Acquired Immune Defic Syndr 1990;3:623–630. [PubMed] [Google Scholar]
  • 27. Pedersen NC, Torten M., Rideout B., et al. Feline leukemia virus infection as a potentiating cofactor for the primary and secondary stages of experimentally induced feline immunodeficiency virus infection. J Virol 1990;64:598–606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Ishida T., Tomoda I. Clinical staging of feline immunodeficiency virus infection. Jpn J Vet Sci 1990;52:645–648. [DOI] [PubMed] [Google Scholar]
  • 29. Hopper CD, Sparkes AH, Gruffydd‐Jones TJ, et al. Clinical and laboratory findings in cats infected with feline immunodeficiency virus. Vet Rec 1989;125: 341–346. [DOI] [PubMed] [Google Scholar]
  • 30. Hosie MJ, Sparkes A., Hopper CD. Feline immunodeficiency virus. In Practice 1989;11:87–95. [Google Scholar]
  • 31. Neu H. FIV(FTLV)‐Infektion der Katze: 11 Fälle—Beitrag zur Epidemiologie, klinischen Symptomatologie und zum Krankheitsverlauf. Kleintierpraxis 1989;34:373–392. [Google Scholar]
  • 32. Lutz H., Lehmann R., Winkler G., et al. Das Feline Immunschwäche Virus in der Schweiz: Klinik und Epidemiologie im Vergleich mit dem Leukämie‐ und dem Coronavirus. Schweiz Arch Tierheilk 1990;132:217–225. [PubMed] [Google Scholar]
  • 33. Remington KM, Cheesebro B., Wehrly K., et al. Mutants of feline immunodeficiency virus resistant to 3′‐azido‐3′‐deoxythymidine. J Virol 1991;65:308–312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. North TW, North GT, Pedersen NC. Feline immunodeficiency virus, a model for reverse transcriptase‐targeted chemotherapy for acquired immune deficiency syndrome. Antimicrob Agents Chemother 1989;33:915–919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Egberink H., Borst M., Niphuis H., et al. Suppression of feline immunodeficiency virus infection in vivo by 9‐ (2‐phosphonometh‐oxyethyl)adenine. Proc Natl Acad Sci USA 1990;87:3087–3091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Dieth V., Lutz H., Hauser B., et al. Pathologische Befunde bei mit Lentiviren infizierten Katzen. Schweiz Arch Tierheilk 1989;131:19–25. [PubMed] [Google Scholar]
  • 37. Yamamoto JK, Hansen H., Ho EW, et al. Epidemiological and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. J Am Vet Med Assoc 1989;194:213–220. [PubMed] [Google Scholar]
  • 38. Shelton GH, Linenberger ML, Grant CK, et al. Hematologic manifestations of feline immunodeficiency virus infection. Blood 1990;76:1104–1109. [PubMed] [Google Scholar]
  • 39. Friend SCE, Birch CJ, Lording PM, et al. Feline immunodeficiency virus: prevalence, disease associations and isolation. Aust Vet J 1990;67:237–243. [DOI] [PubMed] [Google Scholar]
  • 40. Lutz H., Arnold P., Hübscher U., et al. Specifity assessment of feline T‐lymphotropic lentivirus serology. J Vet Med B 1988;35:773–778. [DOI] [PubMed] [Google Scholar]
  • 41. Sachs L. Statistische Methoden: Planung und Auswertung, 6th ed. Berlin , Germany : Springer‐Verlag; 1988:187–191. [Google Scholar]
  • 42. Killingsworth CR, Weiss DJ, Eyster GE, et al. Screening coagulation tests in the cat: Reference values based on direct venipucture and catheterized samples. Vet Clin Pathol 1985;14:19–23. [DOI] [PubMed] [Google Scholar]
  • 43. Pfeil R., Genschow E. Untersuchung zur elektronischen Thrombozytenzählung bei Katze und Hund. Kleintierpraxis 1987;32:119–122. [Google Scholar]
  • 44. Greene CE, Tsang VC, Prestwood AK, et al. Coagulation studies of plasmas from healthy domesticated animals and persons. Am J Vet Res 1981;42:2170–2177. [PubMed] [Google Scholar]
  • 45. O'Rourke L., Feldman BF, Ito RK. Coagulation, fibrinolysis, and kinin generation in adult cats. Am J Vet Res 1982;43:1478–1480. [PubMed] [Google Scholar]
  • 46. Weiser MG, Kociba GJ. Platelet concentration and platelet volume distribution in healthy cats. Am J Vet Res 1984;45:518–522. [PubMed] [Google Scholar]
  • 47. Jain NC, ed. Schalm's Veterinary Hematology, 4th ed. Philadelphia , PA : Lea & Fiebiger, 1986:466–486. [Google Scholar]
  • 48. Kirk RW, ed. Current Veterinary Therapy X. Small Animal Practice. Philadelphia , PA : Saunders; 1989. [Google Scholar]
  • 49. Allen DG, Johnstone IB, Crane S. Effects of aspirin and propranolol alone and in combination on hemostatic determinants in the healthy cat. Am J Vet Res 1985;46:660–663. [PubMed] [Google Scholar]
  • 50. Greene CE. Effects of apirin and propranolol on feline platelet aggregation. Am J Vet Res 1985;46:1820–1823. [PubMed] [Google Scholar]
  • 51. Helenski CA, Ross JN. Platelet aggregation in feline cardiomyopathy. J Vet Intern Med 1987;1:24–28. [DOI] [PubMed] [Google Scholar]
  • 52. MacMillan DC, Sim AK. A comparative study of platelet aggregation in man and laboratory animals. Thrombos Diathes Haemorrh 1970;24:385–394. [PubMed] [Google Scholar]
  • 53. Mills DCB. Platelet aggregation and platelet nucleotide concentration in different species. Symp Zool Soc Lond 1970;27:99–107. [Google Scholar]
  • 54. Tschopp TB. Aggregation of cat platelets in vitro. Thrombos Diath Haemorrh 1970;23:601–620. [PubMed] [Google Scholar]
  • 55. Hart S., Nolte I. Zur Thrombozytenaggregation der Katze. Tierärztl Prax 1991;19:413–418. [PubMed] [Google Scholar]
  • 56. Davenport DJ, Breitschwerdt EB, Caracostas MC. Platelet disorders in the dog and cat. Part I: Physiology and pathogenesis. Compend Contin Educ Pract Vet 1982;4: 762–772. [Google Scholar]
  • 57. Catalfamo JL, Dodds WJ. Hereditary and acquired thrombopathias. Vet Clin North Am Small Anim Pract 1988;18:185–192. [DOI] [PubMed] [Google Scholar]
  • 58. Feldman BF. Disorders of platelets In: Kirk RW, ed. Current Veterinary Therapy. Philadelphia , PA : Saunders; 1989:457–464. [Google Scholar]
  • 59. Cowles BE, Meyers KM, Wardrop KJ, et al. Prolonged bleeding time of Chediak‐Higashi cats corrected by platelet transfusion. Thrombos Haemost 1992;67:708–712. [PubMed] [Google Scholar]
  • 60. Gentry PA, Cooper ML. Reagent dependent variability of plasma clotting times in the cat. Feline Pract 1979;9:33–37. [Google Scholar]
  • 61. Hart S., Nolte I. Schwierigkeiten bei der Gerinnungsdiagnostik der Katze. In: 35. Jahrestagung der Fachgruppe “Kleintierkrankheiten” der DVG, Giessen, 1989:332–338.
  • 62. Greene CE, Meriwether E. Activated partial thromboplastin time and activated coagulation time in monitoring heparinized cats. Am J Vet Res 1982;43:1472–1477. [PubMed] [Google Scholar]
  • 63. Lewis JH. Comparative hematology: Studies on cats including one with factor XII (Hageman) deficiency. Comp Biochem Physiol 1981;68A:355–360(abstr). [Google Scholar]
  • 64. Hoffman L., Sperling K., Dodds WJ. Acquired hemostatic problems in a cat with factor XII deficiency. Feline Pract 1986;16:25–27. [Google Scholar]
  • 65. Lutze G., Kutschmann K. Untersuchungen zum plasmatischen Gerinnungssystem der Hauskatze. Berl Munch Tierärztl Wschr 1991;104:53–57. [PubMed] [Google Scholar]
  • 66. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Hematol 1957;17:237–246. [DOI] [PubMed] [Google Scholar]
  • 67. Schalm OW. Plasma protein: Fibrinogen ratios in routine clinical material from cats, dogs, horses, and cattle—Part III. Calif Vet 1970;24:6–10. [Google Scholar]
  • 68. Pedersen NC. Feline infectious peritonitis: something old, something new. Feline Pract 1976;6:42–51. [Google Scholar]
  • 69. Sutton RH. The value of a single haematological examination in the diagnosis of disease in the cat. J Small Anim Pract 1980;21:339–345. [DOI] [PubMed] [Google Scholar]
  • 70. Lane DA, Scully MF, Thomas DP, et al. Acquired dysfibrinogenaemia in acute and chronic liver disease. Br J Haematol 1977;35:301–308. [DOI] [PubMed] [Google Scholar]
  • 71. Didisheim P., Hattori K., Lewis JH. Hematologic and coagulation studies in various animal species. J Lab Clin Med 1959;53:866–875. [PubMed] [Google Scholar]
  • 72. Green RA, White F. Feline factor XII (Hageman) deficiency. Am J Vet Res 1977;38:893–895. [PubMed] [Google Scholar]
  • 73. Kier AB, Bresnahan JF, White FJ, et al. The inheritance pattern of factor XII (Hageman) deficiency in domestic cats. Can J Comp Med 1980;44:309–314. [PMC free article] [PubMed] [Google Scholar]
  • 74. Feldman BF, Soares CJ, Kitchell BE, et al. Hemorrhage in a cat caused by inhibition of factor XI (plasma thromboplastin antecedent). J Am Vet Med Assoc 1983;182:589–591. [PubMed] [Google Scholar]
  • 75. Littlewood JD. Haemophilia A (factor VIII deficiency) in the cat. J Small Anim Pract 1986;27:541–546. [Google Scholar]
  • 76. French TW, Fox LE, Randolph JF, et al. A bleeding disorder (von Willebrand's disease) in a Himalayan cat. J Am Vet Med Assoc 1987;190:437–439. [PubMed] [Google Scholar]
  • 77. Johnstone IB, Morton JC, Allen DG. Factor VIII deficiency in a cat. Can Vet J 1987;28:671–673. [PMC free article] [PubMed] [Google Scholar]
  • 78. Brooks MB, Dodds WJ. Factor IX deficiency (Hemophilia B) in two male domestic Short‐Hair cats. J Am Anim Hosp Assoc 1989;25:153–155. [Google Scholar]
  • 79. Dodds WJ. Hemostasis In: Kaneko JJ. ed. Clinical Biochemistry of Domestic Animals. San Diego , CA : Academic Press; 1989:274–315. [Google Scholar]
  • 80. Cotter SM, Brenner RM, Dodds WJ. Hemophilia A in three unrelated cats. J Am Vet Med Assoc 1978;172:166–168. [PubMed] [Google Scholar]
  • 81. Dillon AR, Boudreaux MK. Combined factors IX and XII deficiencies in a family of cats. J Am Vet Med Assoc 1988;193:833–834. [PubMed] [Google Scholar]
  • 82. Boudreaux MK, Dillon AR. The effect of danazol treatment on factor IX deficiency in cats. Vet Clin Pathol 1989;17:84–85. [DOI] [PubMed] [Google Scholar]
  • 83. Kitchens CS. Concept of hypercoagulability: A review of its development, clinical application and recent progress. Semin Thrombos Hemost 1985;11:293–315. [DOI] [PubMed] [Google Scholar]
  • 84. Marder VJ, Martin SE, Fracis CW, et al. Consumptive Thrombohemorrhagic Disorders In: Colman RW, Hirsh J., Marder V., Salzman EW, eds. Hemostasis and Thrombosis, 2nd ed. Philadelphia , PA : Lippincott; 1987:975–1015. [Google Scholar]
  • 85. Wenzel E., Holzhüter H., Muschietti F., et al. Zuverlässigkeit des Fibrinogen‐ (Fibrin‐)Spaltproduktnachweises im Plasma mit Thrombinkoagulase‐, Reptilase‐ und Thrombin‐Gerinnungszeit. Dtsch med Wschr 1974;99:746–756. [DOI] [PubMed] [Google Scholar]
  • 86. Lechner K. Acquired inhibitors in nonhemophilic patients. Haemostasis 1974;3:65–93. [DOI] [PubMed] [Google Scholar]
  • 87. Schleider MA, Nachmann RL, Jaffe EA, et al. A clinical study of the lupus anticoagulant. Blood 1976;48:499–509. [PubMed] [Google Scholar]
  • 88. Green D., Lechner K. A survey of 215 nonhemophilic patients with inhibitors to factor VIII. Thrombos Haemost 1981;45:200–203. [PubMed] [Google Scholar]
  • 89. Shaulian MD, Shoenfeld Y., Berliner S., et al. Surgery in patients with circulating lupus anticoagulants. Int Surg 1981;66:157–159. [PubMed] [Google Scholar]

Articles from Journal of Veterinary Internal Medicine are provided here courtesy of Wiley

RESOURCES